PM-02 CONDITIONAL INACTIVATION OF SMARCB1 IN P0 PERMISSIVE MOUSE CELLS GENERATES RHABDOID TUMORS IN THE PERIPHERAL NERVOUS SYSTEM AND IN THE BRAIN

著者: Vitte, Jeremie, Chareyre, Fabrice, Stemmer-Rachamimov, Anat, Judkins, Alexander, Giovannini, Marco
出版年 Neuro Oncol (2015)

Timing of Smarcb1 and Nf2 inactivation determines schwannoma versus rhabdoid tumor development

著者: Vitte, Jeremie, Gao, Fuying, Coppola, Giovanni, Judkins, Alexander R., Giovannini, Marco
出版年 Nat Commun (2017)

TMOD-15. SPATIOTEMPORAL LOSS OF SMARCB1 IN EARLY NEURAL CREST LINEAGE LEADS TO DIFFERENT MOLECULAR SUBTYPES OF RHABDOID TUMORS

著者: Vitte, Jeremie, Gao, Fuying, Coppola, Giovanni, Judkins, Alexander R, Giovannini, Marco
出版年 Neuro Oncol (2019)

Refined Characterization of the Expression and Stability of the SMN Gene Products

著者: Vitte, Jérémie, Fassier, Coralie, Tiziano, Francesco D., Dalard, Cécile, Soave, Sabrina, Roblot, Natacha, Brahe, Christine, Saugier-Veber, Pascale, Bonnefont, Jean Paul, Melki, Judith
出版事項 2007

Deletion of Murine Smn Exon 7 Directed to Liver Leads to Severe Defect of Liver Development Associated with Iron Overload

著者: Vitte, Jérémie M., Davoult, Bénédicte, Roblot, Natacha, Mayer, Michèle, Joshi, Vandana, Courageot, Sabrina, Tronche, François, Vadrot, Jacqueline, Moreau, Marie Helene, Kemeny, François, Melki, Judith
出版事項 2004

mTORC1 inhibition delays growth of neurofibromatosis type 2 schwannoma

著者: Giovannini, Marco, Bonne, Nicolas-Xavier, Vitte, Jeremie, Chareyre, Fabrice, Tanaka, Karo, Adams, Rocky, Fisher, Laurel M., Valeyrie-Allanore, Laurence, Wolkenstein, Pierre, Goutagny, Stephane, Kalamarides, Michel
出版事項 2014

MODL-13. GENETICALLY ENGINEERED PIG MODEL OF RHABDOID TUMOR PREDISPOSITION SYNDROME-1

著者: Na, Brian, Rubinstein, C Dustin, Meudt, Jennifer J, Biegel, Jaclyn A, Judkins, Alexander R, Lehman, Brent P, Reichert, Jamie L, Vitte, Jeremie, Shanmuganayagam, Dhanansayan, Giovannini, Marco
出版年 Neuro Oncol (2020)

Rac1-mediated DNA damage and inflammation promote Nf2 tumorigenesis but also limit cell cycle progression

著者: Shi, Yuhao, Bollam, Saumya R., White, Shannon M., Laughlin, Sean Z., Graham, Garrett T., Wadhwa, Mandheer, Chen, Hengye, Nguyen, Chan, Vitte, Jeremie, Giovannini, Marco, Toretsky, Jeffery, Yi, Chunling
出版年 Dev Cell (2016)

Expanding the mutational spectrum of LZTR1 in schwannomatosis

著者: Paganini, Irene, Chang, Vivian Y, Capone, Gabriele L, Vitte, Jeremie, Benelli, Matteo, Barbetti, Lorenzo, Sestini, Roberta, Trevisson, Eva, Hulsebos, Theo JM, Giovannini, Marco, Nelson, Stanley F, Papi, Laura
出版年 Eur J Hum Genet (2015)

TMOD-23. PRECLINICAL DRUG EVALUATION IN A GENETICALLY ENGINEERED MINIPIG MODEL OF NEUROFIBROMATOSIS TYPE 1

著者: Osum, Sara, Stemmer-Rachamimov, Anat, Widemann, Brigitte, Dombi, Eva, Vitte, Jeremie, Dahiya, Sonika, Rizvi, Tilat, Ratner, Nancy, Messiaen, Ludwine, Gutmann, David, Giovannini, Marco, Moertel, Christopher, Largaespada, David, Watson, Adrienne
出版年 Neuro Oncol (2019)

Therapeutic Potential of HSP90 Inhibition for Neurofibromatosis Type 2

著者: Tanaka, Karo, Eskin, Ascia, Chareyre, Fabrice, Jessen, Walter J., Manent, Jan, Niwa-Kawakita, Michiko, Chen, Ruihong, White, Cory H., Vitte, Jeremie, Jaffer, Zahara M., Nelson, Stanley F., Rubenstein, Allan E., Giovannini, Marco
出版年 Clin Cancer Res (2013)

Update From the 2011 International Schwannomatosis Workshop: From Genetics to Diagnostic Criteria

著者: Plotkin, Scott R., Blakeley, Jaishri O., Evans, D. Gareth, Hanemann, C. Oliver, Hulsebos, Theo J.M., Hunter-Schaedle, Kim, Kalpana, Ganjam V., Korf, Bruce, Messiaen, Ludwine, Papi, Laura, Ratner, Nancy, Sherman, Larry S., Smith, Miriam J., Stemmer-Rachamimov, Anat O., Vitte, Jeremie, Giovannini, Marco
出版事項 2013

Parkin Deficiency Delays Motor Decline and Disease Manifestation in a Mouse Model of Synucleinopathy

著者: Fournier, Margot, Vitte, Jérémie, Garrigue, Jérôme, Langui, Dominique, Dullin, Jean-Philippe, Saurini, Françoise, Hanoun, Naïma, Perez-Diaz, Fernando, Cornilleau, Fabien, Joubert, Chantal, Ardila-Osorio, Héctor, Traver, Sabine, Duchateau, René, Goujet-Zalc, Cécile, Paleologou, Katerina, Lashuel, Hilal A., Haass, Christian, Duyckaerts, Charles, Cohen-Salmon, Charles, Kahle, Philipp J., Hamon, Michel, Brice, Alexis, Corti, Olga
出版事項 2009

Genetically engineered minipigs model the major clinical features of human neurofibromatosis type 1

著者: Isakson, Sara H., Rizzardi, Anthony E., Coutts, Alexander W., Carlson, Daniel F., Kirstein, Mark N., Fisher, James, Vitte, Jeremie, Williams, Kyle B., Pluhar, G. Elizabeth, Dahiya, Sonika, Widemann, Brigitte C., Dombi, Eva, Rizvi, Tilat, Ratner, Nancy, Messiaen, Ludwine, Stemmer-Rachamimov, Anat O., Fahrenkrug, Scott C., Gutmann, David H., Giovannini, Marco, Moertel, Christopher L., Largaespada, David A., Watson, Adrienne L.
出版年 Commun Biol (2018)

Preclinical assessment of MEK1/2 inhibitors for neurofibromatosis type 2–associated schwannomas reveals differences in efficacy and drug resistance development

著者: Fuse, Marisa A, Dinh, Christine T, Vitte, Jeremie, Kirkpatrick, Joanna, Mindos, Thomas, Plati, Stephani Klingeman, Young, Juan I, Huang, Jie, Carlstedt, Annemarie, Franco, Maria Clara, Brnjos, Konstantin, Nagamoto, Jackson, Petrilli, Alejandra M, Copik, Alicja J, Soulakova, Julia N, Bracho, Olena, Yan, Denise, Mittal, Rahul, Shen, Rulong, Telischi, Fred F, Morrison, Helen, Giovannini, Marco, Liu, Xue-Zhong, Chang, Long-Sheng, Fernandez-Valle, Cristina
出版年 Neuro Oncol (2019)